The implementation, co-led by Dr. Alex Sundermann, demonstrates that genomic surveillance does more than identify outbreaks; it directly improves hospital efficiency. By detecting transmission events that conventional methods miss, the hospital achieved measurable reductions in patient length-of-stay and realized net cost savings that offset the investment in sequencing services.

Dr. Paul Rhodes, CEO of NGD Infection Prevention, stated that the award validates the transition toward routine genomic monitoring. This approach allows infection control teams to identify root causes and intervene before pathogens spread further. The hospital utilized high-throughput technology to automate sample preparation and bioinformatics, proving that hospitals can deploy sophisticated diagnostic tools without requiring extensive specialized technician oversight.